Stocktoria

Profound Medical Corp. PROF

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2014-09-24

Profound Medical Corp. statistics & valuation

Market cap$339.4M
P / S21.1×
P / B5.1×
Net margin-264.4%
Return on equity-64.1%
FCF margin-238.4%
Net cash$55.2M
Enterprise value USD$284.2M
Earnings yield EBIT/EV-14.5%
Return on capital-57.8%
Graham number +10%$7.62

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($7.62); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-393.40% -260.40% -264.40% 202320242025
Gross margin (%)
59.90% 65.90% 70.80% 202320242025
Operating margin (%)
-398.00% -309.60% -256.30% 202320242025
Return on equity (%)
-90.70% -46.00% -64.10% 202320242025
Shares outstanding
21.4M 30.0M 36.3M 202320242025
Net debt ($)
-$19.1M -$50.3M -$55.2M 202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-64.40% -39.60% -54.90% 202320242025
Free cash flow margin (%)
-238.40% 202320242025
Debt / equity (×)
0.23× 0.08× 0.07× 202320242025
EPS ($)
$1.34 $1.12 $1.41 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Gross margin70.8%65.9%59.9%
Operating margin-256.3%-309.6%-398.0%
Net margin-264.4%-260.4%-393.4%
FCF margin-238.4%——
Return on assets-54.9%-39.6%-64.4%
Return on equity-64.1%-46.0%-90.7%
Debt / equity0.07×0.08×0.23×
Current ratio12.5210.526.58

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.